Tag: Controlled Substances Act
Hemp Industry Members File Suit Over DEA Regulatory Overreach
WASHINGTON, D.C. – The Hemp Industry Association (HIA) and RE Botanicals, Inc. on Monday filed a complaint in federal court against the Drug Enforcement...
DEA Interim Final Rule Sparks Concern Over Hemp, CBD Product Manufacturing
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration (DEA) issued an interim final rule (IFR) regarding provisions implemented by the 2018 Farm Act and,...
Key DEA Change Could Make Cannabinoid-Based Medicine More Accessible
Washington D.C. – The Drug Enforcement Administration (DEA) is making policy changes that could make it easier for patients to access Epidiolex.
Epidiolex, produced...
FDA Expresses Concern about the Safety of CBD Products
The Food and Drug Administration (FDA) seemed to launch an all-out blitz against CBD’s growing popularity this week. In an update provided by the agency,...
Game-changer: Top Athletes Turn to CBD
CBD products can, and have, changed athletes’ lives. From pain tolerance to concentration, recovery, and stress reduction, professionals are discovering a remarkable breadth of...
House Approves Amendment Calling on FDA to Regulate CBD
WASHINGTON, D.C. – The U.S. House of Representatives has approved a budget amendment that would direct the Food and Drug Administration (FDA) to create...
Federal Trademark Office Opens Door for Hemp and CBD Patents
WASHINGTON, D.C. – Federal authorities overseeing patents and trademarks appear to be signaling a change in regulations for hemp patents.
The United States Patent and...
DEA says it Won’t Prohibit Cannabis Stems, Seeds for Product Use, Sale
WASHINGTON D.C. –The Drug Enforcement Agency on May 22 issued an internal directive that apparently acknowledges some cannabis products are not currently prohibited under...
